The neighborhood’s afflictions date to the early 1970s, when industry left and the drug trade took hold. With each new wave of drugs, the situation grows grimmer. Now, with the arrival of xylazine, a veterinary tranquilizer, new complications are burdening an already overtaxed system.

THERE IS A GROWING INTEREST IN HALLUCINOGENS, especially regarding their application for psychiatric disorders.

The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

COVID VACCINATION OFFERS MORE PROTECTION than being infected by the virus. That’s the conclusion of a new study that seems to confirm what many believe.